They had a long chat over the phone about the drug, which is apparently well tolerated by most people, with side effects being manageable. Although the response rate is relatively low (10-15%) it's a chance worth taking, we think.
The Reading oncologist who uses vinorelbine to treat mesothelioma is on a sabbatical at present, but will be back at work in a couple of months time. It looks likely that Steve will ask for a referral to discuss treatment with him in the autumn, assuming he still feels well enough to take more drugs at that time.
In the meantime we are going to make the most of summer, even if is unseasonably cold, wet and windy at the moment. To find out what we've been up to so far, please read my next post!